Relationship of High-mobility group box 1 levels and multiple sclerosis: A systematic review and meta-analysis
Authors:
- 1 June 2019
- journal article
- review article
- Published by Elsevier in Multiple Sclerosis and Related Disorders
- Vol. 31, 87-92
Abstract
No abstract availableKeywords
Funding Information
- Qingdao Municipal Hospital (ZYZJJ-YJ201814)
This publication has 21 references indexed in Scilit:
- HMGB1 in health and diseaseMolecular Aspects of Medicine, 2014
- High-mobility group box 1 protein (HMGB1) neutralization ameliorates experimental autoimmune encephalomyelitisJournal of Autoimmunity, 2013
- Anti-high mobility group box 1 monoclonal antibody ameliorates experimental autoimmune encephalomyelitisClinical and Experimental Immunology, 2013
- Cerebrospinal Fluid High-Mobility Group Box Protein 1 in Neuromyelitis Optica and Multiple SclerosisNeuroimmunomodulation, 2013
- CSF high-mobility group box 1 is associated with intrathecal inflammation and astrocytic damage in neuromyelitis opticaJournal of Neurology, Neurosurgery & Psychiatry, 2012
- Elevated plasma high-mobility group box 1 protein is a potential marker for neuromyelitis opticaNeuroscience, 2012
- RAGE: a single receptor fits multiple ligandsTrends in Biochemical Sciences, 2011
- HMGB1: A novel Beclin 1-binding protein active in autophagyAutophagy, 2010
- Pivotal Advance: HMGB1 expression in active lesions of human and experimental multiple sclerosisJournal of Leukocyte Biology, 2008
- Chapter 15 The Isolation and Purification of the High Mobility Group (HMG) Nonhistone Chromosomal Proteins1977